[go: up one dir, main page]

JO2726B1 - 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazolin derivatives - Google Patents

4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazolin derivatives

Info

Publication number
JO2726B1
JO2726B1 JO200752A JOP20070052A JO2726B1 JO 2726 B1 JO2726 B1 JO 2726B1 JO 200752 A JO200752 A JO 200752A JO P20070052 A JOP20070052 A JO P20070052A JO 2726 B1 JO2726 B1 JO 2726B1
Authority
JO
Jordan
Prior art keywords
methylaminoquinazolin
benzoylaminophenyl
dimethoxy
derivatives
optionally substituted
Prior art date
Application number
JO200752A
Other languages
Arabic (ar)
Inventor
مايزاكي كازوكي
تاكاسي يوسوتاكا
اسانو اوسامو
شيراتو مانابو
واكيتا هيساشي
سايكي تاكاو
ايشي ناوتو
كوسانو كازوتومي
Original Assignee
ايساي ار و دي مانجمنت كو., ليمتد.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ايساي ار و دي مانجمنت كو., ليمتد. filed Critical ايساي ار و دي مانجمنت كو., ليمتد.
Application granted granted Critical
Publication of JO2726B1 publication Critical patent/JO2726B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A compound represented by the following formula, salt thereof or hydrate thereof, can effectively relieve itch caused by atopic disesae or the like: wherein R represents hydroxyl, C1-6 alkoxy optionally substituted with C1-6 alkoxy, or amino optionally substituted with C1-6 alkyl.
JO200752A 2006-02-21 2007-02-20 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazolin derivatives JO2726B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
JO2726B1 true JO2726B1 (en) 2013-09-15

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200752A JO2726B1 (en) 2006-02-21 2007-02-20 4-(3-Benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazolin derivatives

Country Status (17)

Country Link
JP (1) JP4778550B2 (en)
KR (1) KR101278852B1 (en)
AT (1) ATE517875T1 (en)
BR (1) BRPI0708098B8 (en)
CY (1) CY1112554T1 (en)
DK (1) DK1992622T3 (en)
ES (1) ES2368089T3 (en)
HR (1) HRP20110604T1 (en)
IL (1) IL193322A (en)
JO (1) JO2726B1 (en)
MY (1) MY146275A (en)
NZ (1) NZ569936A (en)
PT (1) PT1992622E (en)
RS (1) RS51969B (en)
RU (1) RU2431632C2 (en)
SI (1) SI1992622T1 (en)
TW (1) TWI404709B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2678477A1 (en) 2007-02-16 2008-08-21 Eisai R&D Management Co., Ltd. Crystal, amorphous form and salt of methyl n-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
JP5060561B2 (en) 2007-08-17 2012-10-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 New topical preparation
KR20100042245A (en) 2007-08-17 2010-04-23 에자이 알앤드디 매니지먼트 가부시키가이샤 Method for producing quinazoline derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9300059D0 (en) * 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
US6262069B1 (en) * 1997-08-29 2001-07-17 Protherics Molecular Design Limited 1-amino-7-isoquinoline derivatives as serine protease inhibitors
AR015966A1 (en) * 1997-10-17 2001-05-30 Smithkline Beecham Corp USE OF A PDE4 INHIBITOR COMPOUND FOR THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR PRURITE TREATMENT
JPH11209350A (en) * 1998-01-26 1999-08-03 Eisai Co Ltd Nitrogen-containing heterocyclic derivative and medicine containing the same
AU2005223610B2 (en) * 2004-03-23 2008-05-29 Banyu Pharmaceutical Co., Ltd. Substituted quinazoline or pyridopyrimidine derivative

Also Published As

Publication number Publication date
RU2008137654A (en) 2010-03-27
TW200812980A (en) 2008-03-16
BRPI0708098A2 (en) 2011-05-17
ATE517875T1 (en) 2011-08-15
KR20080094811A (en) 2008-10-24
MY146275A (en) 2012-07-31
NZ569936A (en) 2010-07-30
RU2431632C2 (en) 2011-10-20
SI1992622T1 (en) 2011-11-30
JPWO2007097317A1 (en) 2009-07-16
CY1112554T1 (en) 2016-02-10
PT1992622E (en) 2011-09-19
HK1122025A1 (en) 2009-05-08
IL193322A (en) 2014-04-30
RS51969B (en) 2012-02-29
TWI404709B (en) 2013-08-11
BRPI0708098B1 (en) 2019-08-06
BRPI0708098B8 (en) 2021-05-25
KR101278852B1 (en) 2013-07-01
JP4778550B2 (en) 2011-09-21
HRP20110604T1 (en) 2011-09-30
IL193322A0 (en) 2009-05-04
DK1992622T3 (en) 2011-09-05
ES2368089T3 (en) 2011-11-14

Similar Documents

Publication Publication Date Title
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
MY158982A (en) Heterocyclic compound
MY150989A (en) Benzothiazole compounds useful for raf inhibition
WO2009028629A1 (en) Heterocyclic compound and use thereof
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
PH12013501873A1 (en) Novel imidazo-oxazine compound or salt thereof
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
WO2009048101A1 (en) Amide compound
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2008019395A3 (en) Compounds for improving learning and memory
WO2008110355A8 (en) Quinoline derivatives as fungicides
WO2008022286A3 (en) Small molecule inhibitors of kynurenine-3-monooxygenase
WO2009025358A1 (en) Heterocyclic compound and use thereof
WO2008057775A3 (en) Heterocyclic amide compounds useful as kinase inhibitors
MX2009011579A (en) Pyrimidinones as casein kinase ii (ck2) modulators.
WO2010027236A3 (en) Fused heterocyclic compound
WO2008140066A3 (en) Pyridone derivatives as p38a mapk inhibitors
AU2012310674B2 (en) Radioactive fluorine labeled compound
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
GB201305247D0 (en) Amide Compounds
WO2009097515A3 (en) [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
CY1112554T1 (en) 4- (3-benzoylaminophenyl) -6,7-dimethoxy-2-methyl-quinazoline derivative
WO2010019203A8 (en) Antifungal agents
PH12013501147A1 (en) Halogenated biphenols as antibacterial agents